SUMMARY Vitreous samples were obtained from 41 eyes undergoing vitrectomy, and radioimmunoassays were performed to measure concentrations of the prostaglandins PGE2, PGF2a, prostacyclin, and thromboxane. Presumably physiological levels (approximately 100 picograms/ml) were found in vitreous from eyes undergoing cataract extraction. Eyes with vitreous haemorrhage, retinal detachment, or cystoid macular oedema had similarly low levels. Vitreous prostaglandins were mildly elevated in trauma and endophthalmitis and markedly elevated in aphakic bullous keratopathy. The role prostaglandins may play in cystoid macular oedema is reviewed.
Prostaglandins are important mediators of inflammation, and the synthesis of these vasoactive prostaglandin compounds (PGE2, PGF2a, prostacyclin [PGI2] ) by ocular tissues has been demonstrated. Low levels of these prostaglandins are found in normal human aqueous. A variety of conditions in which anterior chamber inflammation is present (keratitis, paracentesis, panretinal photocoagulation, etc.) have higher aqueous levels.' Elevated aqueous levels have also been found in association with aphakic cystoid macular oedema. Several investigators believe that prostaglandins synthesised in the anterior segment (as in iris and ciliary body) diffuse through the vitreous and then act on retinal capillaries to produce macular oedema.56 Miyake, Yannuzzi, Klein, and others have reported clinical trials in which a topical or oral prostaglandin inhibitor, indomethacin, given preoperatively and in the early postoperative period was associated with a lower incidence of fluorescein angiographic aphakic cystoid macular oedema.7-" Miyake also noted concurrent reduction in aqueous prostaglandin levels and clinical improvement in the cystoid macular oedema. Furthermore, Miyake et al. have reported 12 elevated aqueous prostaglandins in eyes which developed cystoid macular oedema after intracapsular cataract extraction with vitreous loss and vitreous incarceration to the wound. Pars plana vitrectomy led to lower aqueous prostaglandins and improvement in the oedema of relatively short duration. 12 Despite extensive speculation that prostaglandins, which are synthesised anteriorly, pass through the vitreous and play a pathological role in the posterior pole, concentrations of prostaglandins in the vitreous itself have not been reported either in normal or in diseased eyes. We have therefore measured vitreous prostaglandin levels in 41 eyes, two of which had cystoid macular oedema, and have identified factors possibly associated with elevated vitreous prostaglandins.
Materials and methods
Vitreous specimens were obtained during intraocular surgery on 41 eyes. In six cases vitreous presentation occurred during cataract extraction, thus necessitating an anterior vitrectomy. Fifteen eyes had vitreous haemorrhage. Six had retinal detachment without vitreous haemorrhage, five had aphakic bullous keratopathy (ABK), for which penetrating keratoplasties and anterior vitrectomies were performed; three had trauma, two had cystoid macular oedema, one had endophthalmitis, and three had miscellaneous indications for vitrectomy. To allow accurate determination of prostaglandin concentration we attempted to remove specimens from the eye before dilution by balanced salt solution (BSS) infusion occurred. In the 18 14 Briefly, antisera were raised against each PG by immunising rabbits with PGE2, PGF2a, 6- keto-PGF,a (the chemically stable transformation product of PGI2) and TXB2 (the chemically stable product of thromboxane A2) coupled to human serum albumin. 0. 1 ml of vitreous fluid was added to 100 Rl rabbit anti-PG antibody (in 0-1 M Tris buffer, pH 7-4) and 100 jl tritiated PG. The mixture was incubated at 37°C for one hour. 0.1 ml of normal rabbit serum (1:25 dilution) and 100 Rl goat antirabbit globulin (1:8 dilution) were then added. After thoroughly mixing the reaction mixture was incubated at 4°C overnight. The antibody-bound tritiated PG was sedimented by centrifugation, the supernatant was discarded, and the precipitate was counted for radioactivity.
There was less than 1% cross-reactivity between the PGE2 antibody and PGF2a, 6-keto-PGF,a, and TXB2; between the PGF2. antibody and PGE2, 6- keto-PGF,a, and TXB2; or between the TXB2 antibody and PGE2, PGF2c, and 6-keto-PGF,a. The lowest limit of sensitivity of these assays was 10 pg/ml, and the intra-assay coefficient of variation was less than 10%.
To evaluate further the validity and accuracy of these radioimmunoassay techniques, 6-keto-PGF,a was added to eight samples. Analysis of these specimens by radioimmunoassay showed a recovery of 101±7%.' Similarly, assays performed before and after the addition of PGE2 showed a recovery of 75±19%. In addition plasma levels of prostaglandins measured by the radioimmunoassay procedures described above are similar to those determined by gas chromatography/mass spectrophotometry. 16 
Results
A brief clinical description of the cases and prostaglandin concentrations are listed in Table 1 . Table 2 gives the mean prostaglandin levels for each group of cases. Ages ranged from 28 to 88 years with 70% between 60 and 79. Thirty-seven were men, four were women. Thirty-five of the 41 were Caucasian. Preoperatively visual acuity was less than 20/200 in 30 of the eyes (73%). Twenty-seven (66%) were phakic, 14 (34%) aphakic. Fifteen eyes (37%) had conjunctival injection and/or anterior chamber reaction as evidence of anterior segment inflammation (graded 0 to 4+ in Table 1 .) Follow-up was greater than six months in 20 eyes, three to six months for 12 eyes, and for nine eyes the patient was either lost to follow-up or died within three months. Visual acuity improved or remained the same in 31 eyes, decreased in five eyes and five eyes were lost to follow-up. Postoperatively three eyes had slight progression of pre-existing cataracts (nuclear sclerosis); no new cataracts developed. Three eyes developed recurrent retinal detachments; no postoperative detachments occurred in previously attached retinas.
It is not surprising that quiet eyes undergoing routine cataract extraction had very low, presumably physiological, concentrations of vitreous prostaglandins. The levels found in these vitreous samples corresponded well with previously reported normal aqueous levels (around 100 pg/ml).
Neither vitreous haemorrhage nor the presence of a retinal detachment produced prostaglandins in any greater concentration than in the cataract patients.
Since there was no appreciable inflammation in these eyes, the low levels are what would be expected. In three of the five ABK eyes PGE2 levels were greater than 1000 pg/ml with a mean value of 2569 pg/ml. It is unknown whether prostaglandins may play a causative role in such cases of corneal decompensation or whether elevated levels are coincidental. It is known that principal sites of PGE2 synthesis are the iris and ciliary body. In the case with the highest level (10 000 pg/ml) dense vitreous adhesions to the iris and Copeland intraocular lens were present. Traction by vitreous strands on the iris/ciliary body may thus have stimulated prostaglandin synthesis.
One of the miscellaneous cases with synechiae between the posterior lens capsule and the anterior hyaloid face also had extremely high prostaglandin (PGE2 34 615 pg/ml, 6-keto-PG,, 1523 pg/ml).
Synechial adhesions may have led to traction on the iris and thus stimulated synthesis. The mere presence of vitreous in the anterior chamber (with or without corneal touch) did not substantially raise prostaglandin levels.
In our cases anterior inflammation as indicated by cells or flare or conjunctival injection was not associated with higher vitreous prostaglandin levels. In the one case of confirmed posterior segment inflammation (fungal endophthalmitis in an intravenous drug abuser) vitreous prostaglandins were only moderately elevated.
Of the two cases of cystoid macular oedema one had flagrant oedema associated with vitreous to the wound. Unfortunately this was one of the first specimens obtained, and it was diluted with BSS. In the second case the primary diagnosis was aphakic bullous keratopathy, but mild cystoid macular oedema had been demonstrated on a previous fluorescein angiogram. In both cases prostaglandins were undetectably low.
Discussion
Prostaglandins may well be involved in a variety of fundus disorders. Of all the pathological states in which these compounds are suspected, cystoid macular oedema is one of the most important. The evidence implicating prostaglandins in the aetiology of cystoid macular oedema is two-fold. First, an association between elevated aqueous prostaglandins and cystoid macular oedema has been shown. Miyake reported substantial amounts of PGE and PGF2. (both at concentrations of approximately 13 000 pg/ml) in the aqueous of patients after cataract extraction.5 Furthermore, he reported marked elevation of PGE and PGF2a in the aqueous of nine eyes which had undergone intracapsular cataract extraction with vitreous loss, vitreous incarceration to the wound, and severe cystoid macular oedema.'2 After pars plana vitrectomy the levels were markedly reduced and fluorescein fundus angiography findings improved in five cases with relatively short duration cystoid macular oedema.
Earlier investigators had shown improvement in cystoid macular oedema by relieving vitreous incarceration to the wound. In the 1960s Iliff described a procedure to cut and remove vitreous strands that were anchored by adhesions to the cataract wound in patients with macular oedema. Vision improved in eight of his nine patients.'7 Gass and Norton noted inflammation in most eyes with formed vitreous to the wound and thus performed partial, open-sky anterior vitrectomies to reduce the inflammation and improve acuity. Of nine eyes so treated four remained unchanged, but five improved to 20/40 acuity or better within six months.'8 After the introduction of vitrectomy instruments Fung'9 and Federman et al. 20 each produced series of patients receiving vitrectomies for angiographically demonstrated cystoid macular oedema. Three quarters of their cases had at least a two-line improvement in acuity. Fung has summarised surgical therapy for chronic aphakic cystoid macular oedema and described the national, prospective, randomised, controlled study currently under way to assess the value of vitrectomy in this condition. 21 These clinical demonstrations that resolving vitreous incarceration and mechanical iris irritation improves cystoid macular oedema are consistent with the hypothesis that such irritation produces a mediator which in turn produces cystoid macular oedema. That such a mediator is in fact involved, and that it is a prostaglandin, is not yet proved.
The second category of evidence implicating prostaglandins in cystoid macular oedema is the effect of prostaglandin inhibitors (like indomethacin) on the incidence of this condition. In Miyake's series of 25 cases of bilateral extraction of senile cataracts, topical indomethacin in one eye led to decreased incidence and severity of cystoid macular oedema compared with the fellow eye.8 In Yannuzzi et al.'s series 100 patients undergoing cataract extraction received 1% topical indomethacin four times a day for four to six weeks and had significantly less aphakic cystoid macular oedema five weeks postoperatively (18% vs. 36% for controls), but there was no significant difference at 10 weeks. 
